GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » BioGaia AB (LTS:0GTN) » Definitions » Pretax Margin %

BioGaia AB (LTS:0GTN) Pretax Margin % : 41.54% (As of Mar. 2024)


View and export this data going back to 2013. Start your Free Trial

What is BioGaia AB Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. BioGaia AB's Pre-Tax Income for the three months ended in Mar. 2024 was kr154 Mil. BioGaia AB's Revenue for the three months ended in Mar. 2024 was kr370 Mil. Therefore, BioGaia AB's pretax margin for the quarter that ended in Mar. 2024 was 41.54%.

The historical rank and industry rank for BioGaia AB's Pretax Margin % or its related term are showing as below:

LTS:0GTN' s Pretax Margin % Range Over the Past 10 Years
Min: 30.46   Med: 36.75   Max: 40.55
Current: 36.28


LTS:0GTN's Pretax Margin % is ranked better than
96.27% of 1020 companies
in the Drug Manufacturers industry
Industry Median: 4.185 vs LTS:0GTN: 36.28

BioGaia AB Pretax Margin % Historical Data

The historical data trend for BioGaia AB's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioGaia AB Pretax Margin % Chart

BioGaia AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Pretax Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 31.53 30.46 32.19 40.55 36.16

BioGaia AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 41.16 32.38 40.30 29.62 41.54

Competitive Comparison of BioGaia AB's Pretax Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, BioGaia AB's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioGaia AB's Pretax Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, BioGaia AB's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where BioGaia AB's Pretax Margin % falls into.



BioGaia AB Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

BioGaia AB's Pretax Margin for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Margin=Pre-Tax Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=468.834/1296.505
=36.16 %

BioGaia AB's Pretax Margin for the quarter that ended in Mar. 2024 is calculated as

Pretax Margin=Pre-Tax Income (Q: Mar. 2024 )/Revenue (Q: Mar. 2024 )
=153.599/369.796
=41.54 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BioGaia AB  (LTS:0GTN) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


BioGaia AB Pretax Margin % Related Terms

Thank you for viewing the detailed overview of BioGaia AB's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


BioGaia AB (LTS:0GTN) Business Description

Traded in Other Exchanges
Address
Kungsbroplan 3A, Stockholm, SWE, SE-112 27
BioGaia AB is a healthcare company engaged in developing, marketing, and selling probiotic products. The company has three operating segments; Paediatrics segment includes drops, gut health tablets, oral rehydration solution (ORS) and cultures to be used as ingredients in licensee products such as infant formula, as well as royalty revenue for pediatric products, Adult Health segment includes gut health tablets, oral health lozenges and cultures as an ingredient in a licensee's dairy products, and Other segment include royalties in respect of development projects, revenue from packaging solutions in the subsidiary CapAble, etc. Geographically, it operates in three regions; Asia Pacific, Europe, the Middle East, Africa, and the Americas.

BioGaia AB (LTS:0GTN) Headlines

No Headlines